ABIVAX Société Anonyme (ABVX.PA)
EUR 6.49
(0.15%)
EUR 6.49
(0.15%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -3.43 EUR | -9.58% |
| 2022 | -3.13 EUR | -26.72% |
| 2021 | -2.47 EUR | 5.73% |
| 2020 | -2.62 EUR | -4.38% |
| 2019 | -2.51 EUR | -60.9% |
| 2018 | -1.56 EUR | -36.84% |
| 2017 | -1.14 EUR | 22.97% |
| 2016 | -1.48 EUR | 10.3% |
| 2015 | -1.65 EUR | -89.66% |
| 2014 | -1171.27 EUR | -35.94% |
| 2013 | -852.28 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -1.30 EUR | 0.0% |
| 2023 Q2 | -1.45 EUR | 0.0% |
| 2023 FY | - EUR | -9.58% |
| 2023 Q4 | -1.91 EUR | 0.0% |
| 2022 Q2 | -1.76 EUR | 0.0% |
| 2022 Q4 | -1.81 EUR | 0.0% |
| 2022 FY | - EUR | -26.72% |
| 2021 FY | - EUR | 5.73% |
| 2021 Q2 | -1.13 EUR | 0.0% |
| 2021 Q4 | -1.48 EUR | 0.0% |
| 2020 Q2 | -1.26 EUR | 0.0% |
| 2020 Q4 | -1.55 EUR | 0.0% |
| 2020 FY | - EUR | -4.38% |
| 2019 Q2 | -1.38 EUR | 0.0% |
| 2019 FY | - EUR | -60.9% |
| 2019 Q4 | -1.35 EUR | 0.0% |
| 2018 FY | - EUR | -36.84% |
| 2018 Q4 | -0.82 EUR | 0.0% |
| 2018 Q2 | -0.73 EUR | 0.0% |
| 2017 FY | - EUR | 22.97% |
| 2017 Q4 | -0.56 EUR | 0.0% |
| 2017 Q2 | -0.57 EUR | 0.0% |
| 2016 FY | - EUR | 10.3% |
| 2016 Q2 | -0.86 EUR | 0.0% |
| 2016 Q4 | -0.61 EUR | 0.0% |
| 2015 Q2 | -0.74 EUR | 0.0% |
| 2015 FY | - EUR | -89.66% |
| 2015 Q4 | -0.89 EUR | 0.0% |
| 2014 Q4 | -640.20 EUR | -199962.5% |
| 2014 FY | - EUR | -35.94% |
| 2014 Q1 | - EUR | 0.0% |
| 2014 Q2 | - EUR | 0.0% |
| 2014 Q3 | -0.32 EUR | 0.0% |
| 2013 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -2758.333% |
| Adocia SA | -1.91 EUR | -79.581% |
| Aelis Farma SA | -0.39 EUR | -779.487% |
| Biophytis S.A. | -12.55 EUR | 72.669% |
| Advicenne S.A. | -0.67 EUR | -411.94% |
| genOway Société anonyme | 0.17 EUR | 2117.647% |
| IntegraGen SA | -0.03 EUR | -13143.243% |
| Medesis Pharma S.A. | -0.80 EUR | -328.75% |
| Neovacs S.A. | -0.00 EUR | -137100.0% |
| NFL Biosciences SA | -0.46 EUR | -645.652% |
| Plant Advanced Technologies SA | 0.07 EUR | 5000.0% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -3669.231% |
| Sensorion SA | -0.17 EUR | -1917.647% |
| Theranexus Société Anonyme | -0.88 EUR | -289.773% |
| TME Pharma N.V. | -1.34 EUR | -155.97% |
| Valbiotis SA | -0.59 EUR | -481.356% |
| TheraVet SA | -0.49 EUR | -600.0% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -2186.667% |
| DBV Technologies S.A. | -0.71 EUR | -383.099% |
| Genfit S.A. | -0.58 EUR | -491.379% |
| GeNeuro SA | -0.59 EUR | -481.356% |
| Innate Pharma S.A. | -0.09 EUR | -3545.058% |
| Inventiva S.A. | -2.43 EUR | -41.152% |
| MaaT Pharma SA | -1.73 EUR | -98.266% |
| MedinCell S.A. | -0.88 EUR | -289.773% |
| Nanobiotix S.A. | -1.08 EUR | -217.593% |
| OSE Immunotherapeutics SA | -1.18 EUR | -190.678% |
| Poxel S.A. | -0.91 EUR | -276.923% |
| GenSight Biologics S.A. | -0.54 EUR | -535.185% |
| Transgene SA | -0.22 EUR | -1459.091% |
| Valneva SE | -0.73 EUR | -369.863% |